Rating History for Jazz Pharmaceuticals (JAZZ) by Piper Sandler

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/4/2026 David Amsellem Maintain Overweight
(N/A)
310.00
(301.00)
 
 
  Details